| Source HCPCS Code |
|
Target NDC Code |
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-0022-03
REBIF 22 MCG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-0022-09
REBIF 22 MCG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-0044-03
REBIF 44 MCG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-0044-09
REBIF 44 MCG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-0188-01
REBIF REBIDOSE TITRATION PACK
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
4.2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-3322-01
REBIF REBIDOSE 22 MCG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-3322-09
REBIF REBIDOSE 22 MCG/0.5 M
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-3344-01
REBIF REBIDOSE 44 MCG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-3344-09
REBIF REBIDOSE 44 MCG/0.5 M
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
⇄
|
44087-8822-01
REBIF TITRATION PACK
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
4.2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|